Regentatlantic Capital LLC Johnson & Johnson Transaction History

Regentatlantic Capital LLC

$3.34 Billion
Q3 2022

A detailed history of Regentatlantic Capital LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Regentatlantic Capital LLC holds 213,405 shares of JNJ stock, worth $30.8 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares

213,405

Previous 211,611 0.85%

Holding current value

$30.8 Million

Previous $37.6 Million 7.19%

% of portfolio

1.04%

Previous 1.24%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $289,426 - $322,058	1,794 Added 0.85%	213,405 $34.9 Million
Q2 2022 Aug 15, 2022	BUY	$168.19 - $186.01 $1.21 Million - $1.33 Million	7,172 Added 3.51%	211,611 $37.6 Million
Q1 2022 May 02, 2022	BUY	$158.14 - $179.59 $20,874 - $23,705	132 Added 0.06%	204,439 $36.2 Million
Q4 2021 Jan 27, 2022	SELL	$155.93 - $173.01 $125,055 - $138,754	-802 Reduced 0.39%	204,307 $35 Million
Q3 2021 Nov 15, 2021	BUY	$161.5 - $179.47 $840,446 - $933,961	5,204 Added 2.6%	205,109 $33.1 Million
Q2 2021 Aug 12, 2021	BUY	$159.48 - $171.07 $673,484 - $722,428	4,223 Added 2.16%	199,905 $32.9 Million
Q1 2021 Apr 29, 2021	BUY	$153.07 - $170.48 $731,215 - $814,382	4,777 Added 2.5%	195,682 $32.2 Million
Q4 2020 Feb 04, 2021	BUY	$137.11 - $157.38 $947,292 - $1.09 Million	6,909 Added 3.75%	190,905 $30 Million
Q3 2020 Oct 13, 2020	BUY	$140.38 - $153.83 $2.26 Million - $2.47 Million	16,076 Added 9.57%	183,996 $27.4 Million
Q2 2020 Aug 13, 2020	BUY	$128.81 - $155.51 $248,345 - $299,823	1,928 Added 1.16%	167,920 $23.6 Million
Q1 2020 May 14, 2020	BUY	$111.14 - $153.99 $293,298 - $406,379	2,639 Added 1.62%	165,992 $21.8 Million
Q4 2019 Feb 04, 2020	SELL	$127.5 - $146.44 $113,475 - $130,331	-890 Reduced 0.54%	163,353 $23.8 Million
Q3 2019 Oct 22, 2019	SELL	$126.95 - $142.14 $943,365 - $1.06 Million	-7,431 Reduced 4.33%	164,243 $21.3 Million
Q2 2019 Jul 23, 2019	SELL	$131.15 - $144.24 $921,984 - $1.01 Million	-7,030 Reduced 3.93%	171,674 $23.9 Million
Q1 2019 May 03, 2019	BUY	$125.72 - $139.79 $1.18 Million - $1.31 Million	9,397 Added 5.55%	178,704 $25 Million
Q4 2018 Jan 30, 2019	BUY	$122.84 - $147.84 $28,376 - $34,151	231 Added 0.14%	169,307 $21.8 Million
Q3 2018 Oct 30, 2018	SELL	$121.58 - $142.88 $152,461 - $179,171	-1,254 Reduced 0.74%	169,076 $23.4 Million
Q2 2018 Jul 31, 2018	SELL	$119.4 - $131.76 $1.14 Million - $1.26 Million	-9,555 Reduced 5.31%	170,330 $20.7 Million
Q1 2018 Apr 23, 2018	BUY	$125.1 - $148.14 $1.87 Million - $2.21 Million	14,942 Added 9.06%	179,885 $23.1 Million
Q4 2017 Jan 23, 2018	SELL	$131.22 - $143.62 $448,509 - $490,893	-3,418 Reduced 2.03%	164,943 $23 Million
Q3 2017 Oct 25, 2017	BUY	$129.47 - $135.38 $21.8 Million - $22.8 Million	168,361	168,361 $21.9 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $378B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Regentatlantic Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regentatlantic Capital LLC with notifications on news.

Account

Regentatlantic Capital LLC Johnson & Johnson Transaction History